{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:13:40Z","timestamp":1790115220484,"version":"4.0.1"},"reference-count":93,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the University of Medicine and Pharmacy of Craiova, Romania"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background\/Objectives: Psoriasis is a chronic dermatological condition with systemic implications, especially with metabolic syndrome (MS). This study evaluated the vicious cycle where obesity and MS exacerbate systemic inflammation that complicates the efficacy of psoriasis therapies by examining the PASI score over a one-year period. Patients were classified into two subgroups: those with psoriasis alone (PSO) and those with both psoriasis and metabolic syndrome (PSO-MS). Methods: A total of 150 patients, half of whom also concomitantly presented with metabolic syndrome, received biologic therapies comprising anti-IL-17, anti-IL-23, and anti-TNF-a, or methotrexate, with PASI scores assessed at baseline and at 3, 6, and 12 months. Results: All treatments showed significant reductions in PASI; however, patients with PSO showed more marked reductions in PASI score than those in the PSO-MS group. Anti-IL-17 treatments produced the greatest sustained long-term improvements, whereas anti-IL-23 produced prompt early improvements. Increases in BMI and leptin concentrations were associated with a modest rate of reduction in PASI score, underlining the impact of obesity and metabolic dysfunction on treatment efficacy. Conclusions: This study highlights the importance of managing comorbidities such as MS in the treatment of psoriasis, as the interplay between systemic inflammation and metabolic health further complicates therapeutic outcomes.<\/jats:p>","DOI":"10.3390\/diagnostics14242887","type":"journal-article","created":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T05:58:27Z","timestamp":1734933507000},"page":"2887","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The Role of Metabolic Syndrome in Psoriasis Treatment Response: A One-Year Comparative Analysis of PASI Progression"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6701-0760","authenticated-orcid":false,"given":"Maria-Lorena","family":"Musta\u021b\u0103","sequence":"first","affiliation":[{"name":"Doctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"Ionescu","sequence":"additional","affiliation":[{"name":"Department of Medical Informatics and Biostatistics, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucre\u021biu","family":"Radu","sequence":"additional","affiliation":[{"name":"Department of Hygiene, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7150-5987","authenticated-orcid":false,"given":"Carmen-Daniela","family":"Neagoe","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana-Viorela","family":"Ahri\u021bculesei","sequence":"additional","affiliation":[{"name":"Doctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radu-Cristian","family":"C\u00eempeanu","sequence":"additional","affiliation":[{"name":"Doctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Matei","sequence":"additional","affiliation":[{"name":"Department of Physical and Rehabilitation Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca-Maria","family":"Amzolini","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Medical Semiology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Cristina","family":"Predoi","sequence":"additional","affiliation":[{"name":"Department of Morphology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona-Laura","family":"Iano\u0219i","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.5114\/ada.2020.94832","article-title":"Pathogenesis of Psoriasis in the \u201cOmic\u201d Era. Part I. Epidemiology, Clinical Manifestation, Immunological and Neuroendocrine Disturbances","volume":"37","author":"Samotij","year":"2020","journal-title":"Adv. Dermatol. Allergol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/bjd.19169","article-title":"Systematic Review Examining Changes over Time and Variation in the Incidence and Prevalence of Psoriasis by Age and Gender","volume":"184","author":"Iskandar","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.2147\/CCID.S420850","article-title":"Cellular Mechanisms of Psoriasis Pathogenesis: A Systemic Review","volume":"16","author":"Wu","year":"2023","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41423-020-0519-3","article-title":"\u201cAutoinflammatory Psoriasis\u201d\u2014Genetics and Biology of Pustular Psoriasis","volume":"18","author":"Uppala","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/1346-8138.14139","article-title":"Pathogenesis of Psoriasis and Development of Treatment","volume":"45","author":"Ogawa","year":"2017","journal-title":"J. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.jid.2019.01.014","article-title":"IL-17 and IL-22 Promote Keratinocyte Stemness in the Germinative Compartment in Psoriasis","volume":"139","author":"Ekman","year":"2019","journal-title":"J. Investig. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jaci.2017.07.004","article-title":"Psoriasis Pathogenesis and the Development of Novel Targeted Immune Therapies","volume":"140","author":"Hawkes","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of Psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.47162\/RJME.61.4.11","article-title":"Hepatic Pathological Features in Na\u00efve Patients with Chronic Hepatitis c Who Have Developed Thyroid Disorder","volume":"61","author":"Popescu","year":"2021","journal-title":"Romanian J. Morphol. Embryol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00403-020-02066-1","article-title":"Gender Differences in Psoriasis: A Swiss Online Psoriasis Survey","volume":"313","author":"Murer","year":"2021","journal-title":"Arch. Dermatol. Res."},{"key":"ref_11","first-page":"164","article-title":"Psoriasis: Gender Perspective on Disease Characteristics and Treatment","volume":"7","author":"Fiocchi","year":"2021","journal-title":"J. Sex-Gend.-Specif. Med."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Levi, S.S., and Ramot, Y. (2018). Gender Differences in Psoriasis. Gender and Dermatology, Springer.","DOI":"10.1007\/978-3-319-72156-9_7"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/ced.14218","article-title":"Sex- and Gender-Associated Clinical and Psychosocial Characteristics of Patients with Psoriasis","volume":"45","author":"Napolitano","year":"2020","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Damiani, G., Bragazzi, N.L., Karimkhani Aksut, C., Wu, D., Alicandro, G., McGonagle, D., Guo, C., Dellavalle, R., Grada, A., and Wong, P. (2021). The Global, Regional, and National Burden of Psoriasis: Results and Insights from the Global Burden of Disease 2019 Study. Front. Med., 8.","DOI":"10.3389\/fmed.2021.743180"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2340\/00015555-3384","article-title":"Psoriasis and Genetics","volume":"100","author":"Dand","year":"2020","journal-title":"Acta Derm. Venereol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Mateu-Arrom, L., and Puig, L. (2023). Genetic and Epigenetic Mechanisms of Psoriasis. Genes, 14.","DOI":"10.20944\/preprints202307.1499.v1"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","article-title":"Pathogenesis and Clinical Features of Psoriasis","volume":"370","author":"Griffiths","year":"2007","journal-title":"Lancet"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1684\/ejd.2012.1802","article-title":"Prevalence of Psoriasis in China: A Population-Based Study in Six Cities","volume":"22","author":"Ding","year":"2012","journal-title":"Eur. J. Dermatol."},{"key":"ref_20","first-page":"e47006","article-title":"The Current Advancement in Psoriasis","volume":"15","author":"Bhagwat","year":"2023","journal-title":"Cureus"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Man, A.-M., Or\u0103san, M.S., Hoteiuc, O.-A., Ol\u0103nescu-Vaida-Voevod, M.-C., and Mocan, T. (2023). Inflammation and Psoriasis: A Comprehensive Review. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242216095"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2147\/CCID.S462797","article-title":"The Role of Interleukin 23\/17 Axis in Psoriasis Management: A Comprehensive Review of Clinical Trials","volume":"17","author":"Potestio","year":"2024","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.beem.2005.07.009","article-title":"Adipose Tissue: A Regulator of Inflammation","volume":"19","author":"Henrichot","year":"2005","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Vata, D., Tarcau, B.M., Popescu, I.A., Halip, I.A., Patrascu, A.I., Gheuca Solovastru, D.-F., Mocanu, M., Chiriac, P.C., and Gheuca Solovastru, L. (2023). Update on Obesity in Psoriasis Patients. Life, 13.","DOI":"10.3390\/life13101947"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3892\/etm.2021.11102","article-title":"Metabolic Comorbidities of Psoriasis (Review)","volume":"23","author":"Branisteanu","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/archinte.163.4.427","article-title":"The Metabolic Syndrome","volume":"163","author":"Park","year":"2003","journal-title":"Arch. Intern. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3390\/diabetology4020015","article-title":"Progress in Understanding Metabolic Syndrome and Knowledge of Its Complex Pathophysiology","volume":"4","author":"Jha","year":"2023","journal-title":"Diabetology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/jdv.18044","article-title":"Psoriasis and Metabolic Syndrome: Implications for the Management and Treatment of Psoriasis","volume":"36","author":"Wu","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Su, R., Zhao, S., Zhang, J., Cao, M., and Peng, S. (2023). Metabolic Influences on T Cell in Psoriasis: A Literature Review. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1279846"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Secchiero, P., Rimondi, E., Marcuzzi, A., Longo, G., Papi, C., Manfredini, M., Fields, M., Caruso, L., Di Caprio, R., and Balato, A. (2024). Metabolic Syndrome and Psoriasis: Pivotal Roles of Chronic Inflammation and Gut Microbiota. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25158098"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/jdv.15879","article-title":"Biologic Therapies Targeting the Interleukin (IL)-23\/IL-17 Immune Axis for the Treatment of Moderate-To-Severe Plaque Psoriasis: A Systematic Review and Meta-Analysis","volume":"34","author":"Erichsen","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.4049\/jimmunol.1800013","article-title":"Discovery of the IL-23\/IL-17 Signaling Pathway and the Treatment of Psoriasis","volume":"201","author":"Hawkes","year":"2018","journal-title":"J. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Jang, D., Lee, A.-H., Shin, H.-Y., Song, H.-R., Park, J.-H., Kang, T.-B., Lee, S.-R., and Yang, S.-H. (2021). The Role of Tumor Necrosis Factor Alpha (TNF-\u03b1) in Autoimmune Disease and Current TNF-\u03b1 Inhibitors in Therapeutics. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22052719"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4103\/0019-5154.53175","article-title":"Biologics: Target-specific treatment of systemic and cutaneous autoimmune diseases","volume":"54","author":"Raychaudhuri","year":"2009","journal-title":"Indian J. Dermatol."},{"key":"ref_35","first-page":"468","article-title":"Psoriasis and Metabolic Syndrome\u2014Scientific Evidence and Therapeutic Implications","volume":"7","author":"Voiculescu","year":"2014","journal-title":"J. Med. Life"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2147\/PTT.S328572","article-title":"Comorbidity in Adult Psoriasis: Considerations for the Clinician","volume":"12","author":"Daugaard","year":"2022","journal-title":"Psoriasis Targets Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1590\/abd1806-4841.20132052","article-title":"Psoriasis: Correlation between Severity Index (PASI) and Systemic Treatment","volume":"88","author":"Silva","year":"2013","journal-title":"An. Bras. Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"278","DOI":"10.4103\/ijd.ijd_420_23","article-title":"Disease Assessment in Psoriasis","volume":"68","author":"Manchanda","year":"2023","journal-title":"Indian J. Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jaad.2003.09.014","article-title":"A 50% Reduction in the Psoriasis Area and Severity Index (PASI 50) Is a Clinically Significant Endpoint in the Assessment of Psoriasis","volume":"50","author":"Carlin","year":"2004","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Nicolescu, A., Ionescu, M., Constantin, M., Ancuta, I., Ionescu, S., Nicule\u021b, E., Lauren\u021biu Tatu, A., Zirpel, H., and Tha\u00e7i, D. (2022). Psoriasis Management Challenges Regarding Difficult-To-Treat Areas: Therapeutic Decision and Effectiveness. Life, 12.","DOI":"10.3390\/life12122050"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Mustata, M.-L., Neagoe, C.-D., Ionescu, M., Predoi, M.-C., Mitran, A.-M., and Ianosi, S.-L. (2024). Clinical Implications of Metabolic Syndrome in Psoriasis Management. Diagnostics, 14.","DOI":"10.3390\/diagnostics14161774"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Kim, J.-E., Kim, J.-S., Jo, M.-J., Cho, E., Ahn, S.-Y., Kwon, Y.-J., and Ko, G.-J. (2022). The Roles and Associated Mechanisms of Adipokines in Development of Metabolic Syndrome. Molecules, 27.","DOI":"10.3390\/molecules27020334"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jaad.2012.08.015","article-title":"Psoriasis and Metabolic Syndrome: A Systematic Review and Meta-Analysis of Observational Studies","volume":"68","author":"Armstrong","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3899\/jrheum.120237","article-title":"Metabolic Syndrome in Patients with Psoriatic Disease","volume":"89","author":"Gelfand","year":"2012","journal-title":"J. Rheumatol. Suppl."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41392-023-01655-6","article-title":"Signaling Pathways and Targeted Therapies for Psoriasis","volume":"8","author":"Guo","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Ioni\u021b\u0103-Radu, F., Nicolau, I.-N., Petrache, O.-G., Gro\u0219eanu, M.-L., Bojinc\u0103, V.-C., Negru, M.-M., Bucuric\u0103, S., and Anghel, D. (2024). Correlation between Trabecular Bone Score and Homocysteine Level in Rheumatoid Arthritis Patients on Anti-TNF Inhibitors. Life, 14.","DOI":"10.3390\/life14040463"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Pinter, A., Schwarz, P., Gerdes, S., Simon, J.C., Saalbach, A., Rush, J., Melzer, N., Kramps, T., H\u00e4berle, B., and Reinhardt, M. (2021). Biologic Treatment in Combination with Lifestyle Intervention in Moderate to Severe Plaque Psoriasis and Concomitant Metabolic Syndrome: Rationale and Methodology of the METABOLyx Randomized Controlled Clinical Trial. Nutrients, 13.","DOI":"10.3390\/nu13093015"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1111\/jdv.15077","article-title":"Psoriasis Area and Severity Index Response in Moderate-Severe Psoriatic Patients Switched to Adalimumab: Results from the OPPSA Study","volume":"32","author":"Talamonti","year":"2018","journal-title":"JEADV J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jaad.2021.06.883","article-title":"Comorbid Obesity and History of Diabetes Are Independently Associated with Poorer Treatment Response to Biologics at 6 Months: A Prospective Analysis in Corrona Psoriasis Registry","volume":"86","author":"Enos","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/bjd\/ljae147","article-title":"Insulin Resistance Impairs Biologic Agent Response in Moderate-To-Severe Plaque Psoriasis: Insights from a Prospective Cohort Study in China","volume":"191","author":"Huang","year":"2024","journal-title":"Br. J. Dermatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1080\/09546634.2021.1898528","article-title":"Clinical Implications and Predictive Values of Early PASI Responses to Tildrakizumab in Patients with Moderate-To-Severe Plaque Psoriasis","volume":"33","author":"Feldman","year":"2022","journal-title":"J. Dermatol. Treat."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nri1001","article-title":"Interleukin-12 and the Regulation of Innate Resistance and Adaptive Immunity","volume":"3","author":"Trinchieri","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S1074-7613(00)00070-4","article-title":"Novel P19 Protein Engages IL-12p40 to Form a Cytokine, IL-23, with Biological Activities Similar as Well as Distinct from IL-12","volume":"13","author":"Oppmann","year":"2000","journal-title":"Immunity"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Liu, T., Li, S., Ying, S., Tang, S., Ding, Y., Li, Y., Qiao, J., and Fang, H. (2020). The IL-23\/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.594735"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","article-title":"Advances in the Pathogenesis of Psoriasis: From Keratinocyte Perspective","volume":"13","author":"Zhou","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1111\/jdv.14433","article-title":"The Role of IL-23 and the IL-23\/TH 17 Immune Axis in the Pathogenesis and Treatment of Psoriasis","volume":"31","author":"Girolomoni","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Krueger, J.G., Eyerich, K., Kuchroo, V.K., Ritchlin, C.T., Abreu, M.T., Elloso, M.M., Fourie, A., Fakharzadeh, S., Sherlock, J.P., and Yang, Y.-W. (2024). IL-23 Past, Present, and Future: A Roadmap to Advancing IL-23 Science and Therapy. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1331217"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.4049\/jimmunol.155.12.5483","article-title":"Human IL-17: A Novel Cytokine Derived from T Cells","volume":"155","author":"Yao","year":"1995","journal-title":"J. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Mechanisms of disease: Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.jid.5701213","article-title":"Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T Cells","volume":"128","author":"Lowes","year":"2008","journal-title":"J. Investig. Dermatol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"105841","DOI":"10.1016\/j.intimp.2019.105841","article-title":"Treatment of Plaque Psoriasis with IL-23p19 Blockers: A Systematic Review and Meta-Analysis","volume":"75","author":"Xu","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"ref_62","first-page":"229","article-title":"Onset of Action of Antipsoriatic Drugs for Moderate-to-Severe Plaque Psoriasis: An Update","volume":"18","author":"Yao","year":"2019","journal-title":"J. Drugs Dermatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/jdv.15920","article-title":"Systematic review on rapidity of onset of action for interleukin-17 and interleukin-23 inhibitors for psoriasis","volume":"34","author":"Egeberg","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_64","first-page":"71","article-title":"Durability and Long-Term Outcomes of Biologic Therapies in Psoriasis","volume":"20","author":"Puig","year":"2023","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jaci.2019.10.041","article-title":"Short-Term Transcriptional Response to IL-17 Receptor-A Antagonism in the Treatment of Psoriasis","volume":"145","author":"Tomalin","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","article-title":"Therapeutics Targeting the IL-23 and IL-17 Pathway in Psoriasis","volume":"397","author":"Ghoreschi","year":"2021","journal-title":"Lancet"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s13555-021-00483-2","article-title":"Interleukin-17 and Interleukin-23: A Narrative Review of Mechanisms of Action in Psoriasis and Associated Comorbidities","volume":"11","author":"Menter","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Anghel, D., S\u00eerbu, C.A., Petrache, O.-G., Opri\u0219-Belinski, D., Negru, M.M., Bojinc\u0103, V.-C., Ple\u0219a, C.F., and Ioni\u021b\u0103 Radu, F. (2023). Nailfold Videocapillaroscopy in Patients with Rheumatoid Arthritis and Psoriatic Arthropathy on ANTI-TNF-ALPHA Therapy. Diagnostics, 13.","DOI":"10.3390\/diagnostics13122079"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/path.2287","article-title":"TNF-Mediated Inflammatory Disease","volume":"214","author":"Bradley","year":"2008","journal-title":"J. Pathol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1067\/mjd.2002.120568","article-title":"The Immunologic Basis for the Treatment of Psoriasis with New Biologic Agents","volume":"46","author":"Krueger","year":"2002","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.4049\/jimmunol.175.4.2721","article-title":"TNF Inhibition Rapidly Down-Regulates Multiple Proinflammatory Pathways in Psoriasis Plaques","volume":"175","author":"Gottlieb","year":"2005","journal-title":"J. Immunol."},{"key":"ref_72","first-page":"31","article-title":"Role of Inflammatory Cytokines, Growth Factors and Adipokines in Adipogenesis and Insulin Resistance","volume":"45","author":"Prince","year":"2021","journal-title":"Inflammation"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/j.1468-3083.2011.04065.x","article-title":"Obesity and Psoriasis: Body Weight and Body Mass Index Influence the Response to Biological Treatment","volume":"25","author":"Puig","year":"2011","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Zafiriou, E., Daponte, A.I., Siokas, V., Tsigalou, C., Dardiotis, E., and Bogdanos, D.P. (2021). Depression and Obesity in Patients with Psoriasis and Psoriatic Arthritis: Is IL-17-Mediated Immune Dysregulation the Connecting Link?. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.699848"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jbspin.2018.03.007","article-title":"Impact of Obesity on the Efficacy of Different Biologic Agents in Inflammatory Diseases: A Systematic Review and Meta-Analysis","volume":"86","author":"Shan","year":"2019","journal-title":"Jt. Bone Spine"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1159\/000156599","article-title":"Impact of Body Mass Index and Obesity on Clinical Response to Systemic Treatment for Psoriasis","volume":"217","author":"Naldi","year":"2008","journal-title":"Dermatology"},{"key":"ref_77","first-page":"404","article-title":"Impact of Body Mass Index on Retention Rates of Anti-TNF-Alfa Drugs in Daily Practice for Psoriasis","volume":"23","author":"Tasin","year":"2011","journal-title":"J. Dermatol. Treat."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Singh, S., Facciorusso, A., Singh, A.G., Casteele, N.V., Zarrinpar, A., Prokop, L.J., Grunvald, E.L., Curtis, J.R., and Sandborn, W.J. (2018). Obesity and Response to Anti-Tumor Necrosis Factor-\u03b1 Agents in Patients with Select Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-Analysis. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0195123"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1093\/rheumatology\/kew326","article-title":"The Influence of Obesity on Response to Tumour Necrosis Factor-\u03b1 Inhibitors in Psoriatic Arthritis: Results from the DANBIO and ICEBIO Registries","volume":"55","author":"Glintborg","year":"2016","journal-title":"Rheumatology"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1038\/s41467-021-25066-9","article-title":"Enhanced NF-\u039aB Signaling in Type-2 Dendritic Cells at Baseline Predicts Non-Response to Adalimumab in Psoriasis","volume":"12","author":"Ale","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"899","DOI":"10.2147\/IJN.S394957","article-title":"Topical Delivery of ROS-Responsive Methotrexate Prodrug Nanoassemblies by a Dissolvable Microneedle Patch for Psoriasis Therapy","volume":"18","author":"Zhou","year":"2023","journal-title":"Int. J. Nanomed."},{"key":"ref_82","unstructured":"Sm, R., Chowdhury, K., Kamal, S., Mohit, I., Chowdhury, S., Momin, L., and Rahman, S. (2024, November 13). Radiation Induced Skin Injury Including Cancer Versus Application of UV Radiation Therapy for Skin Review Article Radiation Induced Skin Injury Including Cancer Versus Application of UV Radiation Therapy for Skin Disease. Available online: https:\/\/ecronicon.net\/assets\/eccmc\/pdf\/ECCMC-02-00062.pdf."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Dobric\u0103, E.-C., Cozma, M.-A., G\u0103man, M.-A., Voiculescu, V.-M., and G\u0103man, A.M. (2022). The Involvement of Oxidative Stress in Psoriasis: A Systematic Review. Antioxidants, 11.","DOI":"10.3390\/antiox11020282"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1600-0625.2010.01210.x","article-title":"Adipokines and Psoriasis","volume":"20","author":"Gerdes","year":"2011","journal-title":"Exp. Dermatol."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Martinelli, S., Nannini, G., Cianchi, F., Coratti, F., and Amedei, A. (2024). The Impact of Microbiota\u2013Immunity\u2013Hormone Interactions on Autoimmune Diseases and Infection. Biomedicines, 12.","DOI":"10.3390\/biomedicines12030616"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Rosset, F., Mastorino, L., Dapavo, P., Ortoncelli, M., Quaglino, P., and Ribero, S. (2023). Aging Impact in Response to Different Classes of Biological Treatment in Psoriatic Patients: A Real-Life Observational Study. J. Clin. Med., 12.","DOI":"10.3390\/jcm12237215"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1097\/JW9.0000000000000112","article-title":"Gender Perspective in Psoriasis: A Scoping Review and Proposal of Strategies for Improved Clinical Practice by European Dermatologists","volume":"9","author":"Constantin","year":"2023","journal-title":"Int. J. Women\u2019s Dermatol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000095326","article-title":"Leptin as a Proinflammatory Cytokine","volume":"151","author":"Lord","year":"2006","journal-title":"Contrib. Nephrol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.molmed.2015.12.001","article-title":"Leptin Regulation of Immune Responses","volume":"22","author":"Naylor","year":"2016","journal-title":"Trends Mol. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/exd.12162","article-title":"Leptin Induces Secretion of Pro-Inflammatory Cytokines by Human Keratinocytesin Vitro\u2014A Possible Reason for Increased Severity of Psoriasis in Patients with a High Body Mass Index","volume":"22","author":"Xue","year":"2013","journal-title":"Exp. Dermatol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/bjd.19133","article-title":"Leptin Induces Interleukin-6 Production in Keratinocytes via Decreased Expression of Caveolin-1: A Possible Link between Obesity and Psoriatic Inflammation","volume":"183","author":"Watanabe","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/bjd.13969","article-title":"The Role of Leptin in Psoriasis Comprises a Proinflammatory Response by the Dermal Fibroblast","volume":"174","author":"Ommen","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Karampinis, E., Papadopoulou, M.-M., Chaidaki, K., Georgopoulou, K.-E., Magaliou, S., Roussaki Schulze, A.V., Bogdanos, D.P., and Zafiriou, E. (2024). Plaque Psoriasis Exacerbation and COVID-19 Vaccination: Assessing the Characteristics of the Flare and the Exposome Parameters. Vaccines, 12.","DOI":"10.3390\/vaccines12020178"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/14\/24\/2887\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:58:09Z","timestamp":1760115489000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/14\/24\/2887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,23]]},"references-count":93,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["diagnostics14242887"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics14242887","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,23]]}}}